- Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
- Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
- Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
- Carisma Therapeutics to Present at Upcoming Conferences
- Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- Carisma Therapeutics Announces Changes to its Board of Directors
- Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
- Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.64 |
---|---|
High | 1.67 |
Low | 1.58 |
Bid | 1.63 |
Offer | 1.64 |
Previous close | 1.60 |
Average volume | 109.00k |
---|---|
Shares outstanding | 41.54m |
Free float | 27.95m |
P/E (TTM) | -- |
Market cap | 66.47m USD |
EPS (TTM) | -3.70 USD |
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
More ▼